Showing 1 - 14 results of 14 for search 'Nicola Gianotti', query time: 0.07s
Refine Results
-
1
-
2
-
3
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patie... by Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-11-01
Article -
4
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load. by Nadia Galizzi, Laura Galli, Andrea Poli, Nicola Gianotti, Elisabetta Carini, Alba Bigoloni, Giuseppe Tambussi, Silvia Nozza, Adriano Lazzarin, Antonella Castagna, Daniela Mancusi, Roberta Termini
Published 2018-01-01
Article -
5
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic by Rebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, Andrea Poli, Tommaso Clemente, Martina Bottanelli, Nicola Gianotti, Silvia Nozza, Silvia Nozza, Antonella Castagna, Antonella Castagna, Vincenzo Spagnuolo
Published 2023-09-01
Article -
6
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics by Caterina Candela, Angelo Roberto Raccagni, Elena Bruzzesi, Costanza Bertoni, Alberto Rizzo, Gloria Gagliardi, Diana Canetti, Nicola Gianotti, Davide Mileto, Maria Rita Gismondo, Antonella Castagna, Silvia Nozza
Published 2023-03-01
Article -
7
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients. by Nicola Gianotti, Andrea Poli, Laura Galli, Michela Franzin, Patrizia Tadini, Nadia Galizzi, Alessia Carbone, Marco Merli, Camilla Muccini, Chiara Oltolini, Andrea Andolina, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-01-01
Article -
8
HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy. by Davide Croce, Adriano Lazzarin, Giuliano Rizzardini, Nicola Gianotti, Francesca Scolari, Emanuela Foglia, Elisabetta Garagiola, Elena Ricci, Teresa Bini, Tiziana Quirino, Paolo Viganò, Tiziana Re, Antonella D'Arminio Monforte, Paolo Bonfanti
Published 2016-01-01
Article -
9
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic by Alessandra Vergori, Nicola Gianotti, Alessandro Tavelli, Camilla Tincati, Andrea Giacomelli, Elena Matteini, Giuseppe Lapadula, Lucia Taramasso, Loredana Sarmati, Antonella D’Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri, on behalf of the ICONA Foundation Study
Published 2024-11-01
Article -
10
Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation C... by Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Franco Maggiolo, Giuliano Rizzardini, Paolo Emilio Manconi, Nicola Gianotti, Tiziana Quirino, Carmela Pinnetti, Stefano Rusconi, Andrea De Luca, Andrea Antinori, Icona Foundation Study cohort
Published 2016-01-01
Article -
11
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy by Lavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, Stefano Rusconi, Nicola Gianotti, Andrea Costantini, Loredana Sarmati, Andrea Antinori, Francesca Ceccherini-Silberstein, Antonella d’Arminio Monforte, Annalisa Saracino, Enrico Girardi, on behalf of the Icona Foundation Study Cohort
Published 2020-07-01
Article -
12
Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience by Benedetta Trentacapilli, Angelo Roberto Raccagni, Sara Diotallevi, Silvia Nozza, Silvia Nozza, Riccardo Lolatto, Anna Carole D’Amelio, Gaia Catalano, Giacomo Ponta, Vincenzo Spagnuolo, Vincenzo Spagnuolo, Massimo Cernuschi, Nicola Gianotti, Antonella Castagna, Antonella Castagna, Diana Canetti
Published 2025-02-01
Article -
13
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. by Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d'Arminio Monforte, Francesca Ceccherini-Silberstein, Massimo Andreoni, Icona Foundation Study and mono-PI/r database Study Cohorts
Published 2017-01-01
Article -
14
Pillars of long-term antiretroviral therapy success by Lucia Taramasso, Massimo Andreoni, Andrea Antinori, Alessandra Bandera, Paolo Bonfanti, Stefano Bonora, Marco Borderi, Antonella Castagna, Anna Maria Cattelan, Benedetto Maurizio Celesia, Stefania Cicalini, Antonella Cingolani, Andrea Cossarizza, Antonella D'Arminio Monforte, Gabriella D'Ettorre, Antonio Di Biagio, Simona Di Giambenedetto, Giovanni Di Perri, Vincenzo Esposito, Emanuele Focà, Cristina Gervasoni, Andrea Gori, Nicola Gianotti, Giovanni Guaraldi, Roberto Gulminetti, Sergio Lo Caputo, Giordano Madeddu, Paolo Maggi, Giorgio Marandola, Giulia Carla Marchetti, Claudio Maria Mastroianni, Cristina Mussini, Carlo Federico Perno, Giuliano Rizzardini, Stefano Rusconi, Maria Santoro, Loredana Sarmati, Maurizio Zazzi, Franco Maggiolo
Published 2023-10-01
Article